Bernard A. Fox, Co-founder, President, and CEO of UbiVac, shared a post on LinkedIn:
“Delighted to present at the American Association for Cancer Research Cancer Vaccine Coalition HSBC Innovation Banking conference on cancer vaccines
One Question…. Which cancer antigens are important??
That is one question that will be discussed in the session ‘Navigating Existing Challenges in Cancer Vaccine Research and Development’?
Your choices?
1) neoantigens
2) TAA Tumor Associated Antigens Aberantly Expressed antigens
Or
3) Dark Genome-derived Dark Matter antigens also known as noncannonical or cryptic antigens
Do they need to be restricted to cancer ??”
More posts featuring Bernard A. Fox.